We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diffusion-Weighted MRI Becoming Major Tool to Diagnose Patients with Transient Ischemic Attacks

By MedImaging International staff writers
Posted on 20 Aug 2014
Image: The ischemic penumbra is visible in some patients up to 24 hour after stroke by MRI scanning. Perfusion-weighted imaging can be used to show areas of ischemia and can be compared with the ischemic core, visible by diffusion-weighted imaging (Photo courtesy of sharinginginhealth dot ca, an open access training in healthcare resource).
Image: The ischemic penumbra is visible in some patients up to 24 hour after stroke by MRI scanning. Perfusion-weighted imaging can be used to show areas of ischemia and can be compared with the ischemic core, visible by diffusion-weighted imaging (Photo courtesy of sharinginginhealth dot ca, an open access training in healthcare resource).
With the development of brain imaging, including cranial computed tomography (CCT), and particularly diffusion-weighted imaging-magnetic resonance imaging (DWI-MRI), the diagnosis of transient ischemic attacks (TIAs) has changed from time-based definition to a tissue-based one. DWI-MRI became an essential tool in the TIA workup.

Several studies have shown that TIA patients had cerebral infarctions that can be identified by CCT, even though the CCT was performed days to weeks after the TIA. It has been found that 3%–48% of patients with clinical TIA symptoms had acute cerebral infarctions that can be visualized by CCT. Moreover, the DWI-MRI measurements have shown that up to 67% of patients with TIA demonstrate relevant cerebral infarction.

The development of brain imaging and its use in the routine diagnostic workup of patients with TIA has therefore changed the investigators outlook of TIAs. Particularly, the definition of TIA has shifted from a clinically time-based term to tissue-related one in the clinical daily routine.

The risk of stroke after TIA in patients with evidence of acute infarction ranged between 3 to 18-fold higher than TIA patients without acute infarction detected by MRI. Therefore, TIA should be handled as an emergency event and patients suffering from TIA should be immediately treated to evaluate the etiology and to receive the secondary prophylaxis to prevent a stroke. The impact of the immediate evaluation of TIA patients on stroke prevention after TIA has been shown in earlier studies. Conversely, there are no uniform international guidelines and recommendations for TIA diagnosis and treatment, particularly in diagnostic and therapeutic procedures.

The DWI-MRI provides not only the evidence to differentiate between TIA and acute ischemic stroke; furthermore, it predicts TIA patients who are at higher risk of disabling stroke, which can be prevented by an immediate evaluation and treatment of TIA, according to Dr. Mohamed Al-Khaled from the University of Lübeck (Germany).

The brain imaging in patients with transient neurologic symptoms can help to answer the question that whether patients with TIA who have an acute infarction should be classified as acute ischemic stroke. Furthermore, it has been established that TIA patients who showed acute infarction by DWI-MRI or CCT are at a higher risk to suffer from an incapacitating stroke.

These findings were published in the June/July 2014 issue of the journal Neural Regeneration Research (2014; vol. 9, no. 3).

Related Links:

University of Lübeck


Biopsy Software
Affirm® Contrast
Ultrasound Needle Guidance System
SonoSite L25
Mobile X-Ray System
K4W
Ultrasonic Pocket Doppler
SD1

Channels

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.